Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2010 4
2011 5
2012 3
2013 6
2014 7
2015 5
2016 9
2017 6
2018 4
2019 12
2020 9
2021 9
2022 10
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for zhigang bai
Search for Shigang Bai instead (1 results)
Editorial: Angiogenesis blockade for the treatment of gastrointestinal cancer.
Passardi A, Bittoni A, Bai Z, Zhang Z, Sier C, He Y, Shahini E, Solimando AG. Passardi A, et al. Among authors: bai z. Front Oncol. 2023 Feb 1;13:1147849. doi: 10.3389/fonc.2023.1147849. eCollection 2023. Front Oncol. 2023. PMID: 36816979 Free PMC article. No abstract available.
Efficacy and safety of PD-1 blockade plus long-course chemoradiotherapy in locally advanced rectal cancer (NECTAR): a multi-center phase 2 study.
Yang Z, Gao J, Zheng J, Han J, Li A, Liu G, Sun Y, Zhang J, Chen G, Xu R, Zhang X, Liu Y, Bai Z, Deng W, He W, Yao H, Zhang Z. Yang Z, et al. Among authors: bai z. Signal Transduct Target Ther. 2024 Mar 11;9(1):56. doi: 10.1038/s41392-024-01762-y. Signal Transduct Target Ther. 2024. PMID: 38462629 Free PMC article. Clinical Trial.
Long-course chemoradiation plus concurrent/sequential PD-1 blockade as neoadjuvant treatment for MMR-status-unscreened locally advanced rectal cancer: protocol of a multicentre, phase 2, randomised controlled trial (the POLAR-STAR trial).
Pang K, Yang Y, Tian D, Zeng N, Cao S, Ling S, Gao J, Zhao P, Wang H, Kong Y, Zhang J, Chen G, Deng W, Bai Z, Jin L, Wu G, Zhu D, Wang Y, Zhou J, Wu B, Lin G, Xiao Y, Gao Z, Ye Y, Wang X, Li A, Han J, Yao H, Yang Y, Zhang Z. Pang K, et al. Among authors: bai z. BMJ Open. 2023 Sep 12;13(9):e069499. doi: 10.1136/bmjopen-2022-069499. BMJ Open. 2023. PMID: 37699634 Free PMC article.
95 results